About the Authors
- Norma C Serrano
-
*To whom correspondence should be addressed. E-mail: nserrano@unab.edu.co (NCS), Juan.Pablo-Casas@lshtm.ac.uk (JPC)
Affiliation Universidad Aut
- Luis A Díaz
-
Affiliation Universidad Aut
- Maria C Páez
-
Affiliation Universidad Aut
- Clara M Mesa
-
Affiliation Instituto de Ciencias de la Salud, Medell
- Rodrigo Cifuentes
-
Affiliation Universidad del Valle, Cali, Colombia
- Alvaro Monterrosa
-
Affiliation Universidad de Cartagena, Cartagena, Colombia
- Adriana González
-
Affiliation Universidad Industrial de Santander, Bucaramanga, Colombia
- Liam Smeeth
-
Affiliation Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom
- Aroon D Hingorani
-
Affiliation Centre for Clinical Pharmacology, Department of Medicine, at British Heart Foundation laboratories at University College London, London, United Kingdom
- Juan P Casas
-
*To whom correspondence should be addressed. E-mail: nserrano@unab.edu.co (NCS), Juan.Pablo-Casas@lshtm.ac.uk (JPC)
Affiliations Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom , Centre for Clinical Pharmacology, Department of Medicine, at British Heart Foundation laboratories at University College London, London, United Kingdom
Competing Interests
University College London holds patents on the measurement of asymmetric dimethylarginine in the management of preeclampsia.
Author Contributions
NCS, LAD, MCP, RC, AM, LS, ADH, and JPC designed the study. NCS, LAD, MCP, CMM, AM, AG, LS, and JPC analyzed the data. NCS, MCP, CMM, RC, AM, AG, and LS enrolled patients. NCS, LAD, MCP, CMM, AM, AG, LS, ADH, and JPC contributed to writing the paper. MCP genotyped the insertion/deletion within the angiotensin-converting enzyme gene and collected the data for the meta-analysis.